In order to confirm that TRPM2-AS affects CRC cell malignant behavior by miR-22-3p/FSTL1, a rescue assay of FSTL1 overexpression or miR-22-3p inhibition was performed. The gene discussed is TRPM2; the disease is colorectal carcinoma.